Strategic Advocates’s Crocs CROX Stock Holding History

Strategic Advocates’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-57	Closed	-$4.94K	–	334
2025 Q4	$4.94K	Hold	57	–	–	﹤0.01%	431
2025 Q3	$4.76K	Buy	+57	New	+$5.2K	﹤0.01%	414

Other funds holding CROX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WPA

WIT Partners Advisory Singapore $342M AUM 8.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Strategic Advocates's CROX Position: Q1 2026 in Review

Strategic Advocates sold out of Crocs (CROX) in Q1 2026, closing a stake of 57 shares — an estimated $4.94K sold.

Strategic Advocates first reported a position in CROX in Q3 2025 and held it in 2 quarters. The position peaked at $4.94K in Q4 2025. 457 funds tracked by Wall St. Rank hold CROX as of Q1 2026.

Strategic Advocates reported no remaining Crocs position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 57 Crocs shares in Q1 2026, an estimated $4.94K.
Strategic Advocates first reported a position in Crocs in Q3 2025 and held it in 2 quarters.
Strategic Advocates's Crocs position peaked at $4.94K in Q4 2025.
457 funds tracked by Wall St. Rank held Crocs as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.